Gilead Sciences New Supplemental Dug Application Accepted By FDA For Yeztugo 300-Mg Tablet; Regulator Sets Feb. 2, 2027 As Prescription Drug User Fee Act Action Date

뉴스 본문을 불러오고 있어요.

Gilead Sciences New Supplemental Dug Application Accepted By FDA For Yeztugo 300-Mg Tablet; Regulator Sets Feb. 2, 2027 As Prescription Drug User Fee Act Action Date | 웨이프 WAPE

Gilead Sciences New Supplemental Dug Application Accepted By FDA For Yeztugo 300-Mg Tablet; Regulator Sets Feb. 2, 2027 As Prescription Drug User Fee Act Action Date

기사 요약

관련 종목

댓글 —